166 related articles for article (PubMed ID: 38464783)
1. Pyrimethamine upregulates BNIP3 to interfere SNARE-mediated autophagosome-lysosomal fusion in hepatocellular carcinoma.
Wang J; Su Q; Chen K; Wu Q; Ren J; Tang W; Hu Y; Zhu Z; Cheng C; Tu K; He H; Zhang Y
J Pharm Anal; 2024 Feb; 14(2):211-224. PubMed ID: 38464783
[TBL] [Abstract][Full Text] [Related]
2. A novel autophagy inhibitor berbamine blocks SNARE-mediated autophagosome-lysosome fusion through upregulation of BNIP3.
Fu R; Deng Q; Zhang H; Hu X; Li Y; Liu Y; Hu J; Luo Q; Zhang Y; Jiang X; Li L; Yang C; Gao N
Cell Death Dis; 2018 Feb; 9(2):243. PubMed ID: 29445175
[TBL] [Abstract][Full Text] [Related]
3. New insights regarding SNARE proteins in autophagosome-lysosome fusion.
Tian X; Teng J; Chen J
Autophagy; 2021 Oct; 17(10):2680-2688. PubMed ID: 32924745
[TBL] [Abstract][Full Text] [Related]
4. Ketoconazole exacerbates mitophagy to induce apoptosis by downregulating cyclooxygenase-2 in hepatocellular carcinoma.
Chen Y; Chen HN; Wang K; Zhang L; Huang Z; Liu J; Zhang Z; Luo M; Lei Y; Peng Y; Zhou ZG; Wei Y; Huang C
J Hepatol; 2019 Jan; 70(1):66-77. PubMed ID: 30287340
[TBL] [Abstract][Full Text] [Related]
5. SIGMAR1/Sigma-1 receptor ablation impairs autophagosome clearance.
Yang H; Shen H; Li J; Guo LW
Autophagy; 2019 Sep; 15(9):1539-1557. PubMed ID: 30871407
[TBL] [Abstract][Full Text] [Related]
6. Human menstrual blood-derived stem cells reverse sorafenib resistance in hepatocellular carcinoma cells through the hyperactivation of mitophagy.
Zhou S; Liu Y; Zhang Q; Xu H; Fang Y; Chen X; Fu J; Yuan Y; Li Y; Yuan L; Xiang C
Stem Cell Res Ther; 2023 Apr; 14(1):58. PubMed ID: 37005657
[TBL] [Abstract][Full Text] [Related]
7. CDK9 inhibition blocks the initiation of PINK1-PRKN-mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinoma.
Yao J; Wang J; Xu Y; Guo Q; Sun Y; Liu J; Li S; Guo Y; Wei L
Autophagy; 2022 Aug; 18(8):1879-1897. PubMed ID: 34890308
[TBL] [Abstract][Full Text] [Related]
8. Human YKT6 forms priming complex with STX17 and SNAP29 to facilitate autophagosome-lysosome fusion.
Zheng D; Tong M; Zhang S; Pan Y; Zhao Y; Zhong Q; Liu X
Cell Rep; 2024 Feb; 43(2):113760. PubMed ID: 38340317
[TBL] [Abstract][Full Text] [Related]
9. mTOR-mediated phosphorylation of VAMP8 and SCFD1 regulates autophagosome maturation.
Huang H; Ouyang Q; Zhu M; Yu H; Mei K; Liu R
Nat Commun; 2021 Nov; 12(1):6622. PubMed ID: 34785650
[TBL] [Abstract][Full Text] [Related]
10. DIPK2A promotes STX17- and VAMP7-mediated autophagosome-lysosome fusion by binding to VAMP7B.
Tian X; Zheng P; Zhou C; Wang X; Ma H; Ma W; Zhou X; Teng J; Chen J
Autophagy; 2020 May; 16(5):797-810. PubMed ID: 31251111
[TBL] [Abstract][Full Text] [Related]
11. The macrophage-specific V-ATPase subunit ATP6V0D2 restricts inflammasome activation and bacterial infection by facilitating autophagosome-lysosome fusion.
Xia Y; Liu N; Xie X; Bi G; Ba H; Li L; Zhang J; Deng X; Yao Y; Tang Z; Yin B; Wang J; Jiang K; Li Z; Choi Y; Gong F; Cheng X; O'Shea JJ; Chae JJ; Laurence A; Yang XP
Autophagy; 2019 Jun; 15(6):960-975. PubMed ID: 30681394
[TBL] [Abstract][Full Text] [Related]
12. MTOR-mediates hepatic lipid metabolism through an autophagic SNARE complex.
Ouyang Q; Liu R
Autophagy; 2022 Jun; 18(6):1467-1469. PubMed ID: 35174767
[TBL] [Abstract][Full Text] [Related]
13. ATG14 controls SNARE-mediated autophagosome fusion with a lysosome.
Liu R; Zhi X; Zhong Q
Autophagy; 2015; 11(5):847-9. PubMed ID: 25945523
[TBL] [Abstract][Full Text] [Related]
14. Weakened interaction of ATG14 and the SNARE complex blocks autophagosome-lysosome fusion contributes to fluoride-induced developmental neurotoxicity.
Zhang Y; Han X; Tang Y; Zhang J; Hu Z; Xu W; Yao P; Niu Q
Ecotoxicol Environ Saf; 2022 Jan; 230():113108. PubMed ID: 34953272
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis.
Feng J; Dai W; Mao Y; Wu L; Li J; Chen K; Yu Q; Kong R; Li S; Zhang J; Ji J; Wu J; Mo W; Xu X; Guo C
J Exp Clin Cancer Res; 2020 Jan; 39(1):24. PubMed ID: 32000827
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of MYO1C mediated by cepharanthine inhibits autophagosome-lysosome fusion through blockade of the F-actin network.
Zhang Y; Jiang X; Deng Q; Gao Z; Tang X; Fu R; Hu J; Li Y; Li L; Gao N
J Exp Clin Cancer Res; 2019 Nov; 38(1):457. PubMed ID: 31699152
[TBL] [Abstract][Full Text] [Related]
17. Pristimerin synergistically sensitizes conditionally reprogrammed patient derived-primary hepatocellular carcinoma cells to sorafenib through endoplasmic reticulum stress and ROS generation by modulating Akt/FoxO1/p27
Tang Y; Chen J; Li J; Zheng Y; Zhong X; Huang S; Chen B; Peng B; Zou X; Chen X
Phytomedicine; 2021 Jun; 86():153563. PubMed ID: 33951569
[TBL] [Abstract][Full Text] [Related]
18. Berbamine (BBM), a Natural STAT3 Inhibitor, Synergistically Enhances the Antigrowth and Proapoptotic Effects of Sorafenib on Hepatocellular Carcinoma Cells.
Zhao W; Bai B; Hong Z; Zhang X; Zhou B
ACS Omega; 2020 Sep; 5(38):24838-24847. PubMed ID: 33015502
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous treatment with sorafenib and glucose restriction inhibits hepatocellular carcinoma in vitro and in vivo by impairing SIAH1-mediated mitophagy.
Zhou J; Feng J; Wu Y; Dai HQ; Zhu GZ; Chen PH; Wang LM; Lu G; Liao XW; Lu PZ; Su WJ; Hooi SC; Ye XP; Shen HM; Peng T; Lu GD
Exp Mol Med; 2022 Nov; 54(11):2007-2021. PubMed ID: 36385558
[TBL] [Abstract][Full Text] [Related]
20. Carvacrol enhances anti-tumor activity and mitigates cardiotoxicity of sorafenib in thioacetamide-induced hepatocellular carcinoma model through inhibiting TRPM7.
Yousef EH; Abo El-Magd NF; El Gayar AM
Life Sci; 2023 Jul; 324():121735. PubMed ID: 37142088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
